Joris De Wit

Joris De Wit is a co-founder of Augustine Therapeutics, a Belgian biotech developing treatments for neuromuscular and neurodegenerative diseases that raised EUR 77.7M in a Series A round in H1 2025.

Overview

De Wit co-founded Augustine Therapeutics alongside Ludo Van Den Bosch and Bart De Strooper, researchers with strong academic credentials in neuroscience. The EUR 77.7M Series A closed in H1 2025 is one of the larger biotech rounds in recent Belgian history, with PMV among the backers.

Career history

  1. FounderAugustine Therapeutics

In the news

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.